Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial.
- Published In:
- The Lancet. Neurology, 13(7), 676-85 (2014)
- Authors:
- Boxer, Adam L, Lang, Anthony E, Grossman, Murray, Knopman, David S, Miller, Bruce L, Schneider, Lon S, Doody, Rachelle S, Lees, Andrew, Golbe, Lawrence I, Williams, David R, Corvol, Jean-Cristophe, Ludolph, Albert, Burn, David, Lorenzl, Stefan, Litvan, Irene, Roberson, Erik D, Höglinger, Günter U, Koestler, Mary, Jack, Clifford R, Van Deerlin, Viviana, Randolph, Christopher, Lobach, Iryna V, Heuer, Hilary W, Gozes, Illana, Parker, Lesley, Whitaker, Steve, Hirman, Joe, Stewart, Alistair J, Gold, Michael, Morimoto, Bruce H
- Database ID:
- RPEP-02338
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02338APA
Boxer, Adam L; Lang, Anthony E; Grossman, Murray; Knopman, David S; Miller, Bruce L; Schneider, Lon S; Doody, Rachelle S; Lees, Andrew; Golbe, Lawrence I; Williams, David R; Corvol, Jean-Cristophe; Ludolph, Albert; Burn, David; Lorenzl, Stefan; Litvan, Irene; Roberson, Erik D; Höglinger, Günter U; Koestler, Mary; Jack, Clifford R; Van Deerlin, Viviana; Randolph, Christopher; Lobach, Iryna V; Heuer, Hilary W; Gozes, Illana; Parker, Lesley; Whitaker, Steve; Hirman, Joe; Stewart, Alistair J; Gold, Michael; Morimoto, Bruce H. (2014). Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial.. The Lancet. Neurology, 13(7), 676-85. https://doi.org/10.1016/S1474-4422(14)70088-2
MLA
Boxer, Adam L, et al. "Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial.." The Lancet. Neurology, 2014. https://doi.org/10.1016/S1474-4422(14)70088-2
RethinkPeptides
RethinkPeptides Research Database. "Davunetide in patients with progressive supranuclear palsy: ..." RPEP-02338. Retrieved from https://rethinkpeptides.com/research/boxer-2014-davunetide-in-patients-with
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.